60505-6230 Paclitaxel protein-bound particles for injectable suspension (albumin-bound)

Product NDC:

60505-6230

Brand Name:

Paclitaxel protein-bound particles for injectable suspension (albumin-bound)

Generic Name:

Paclitaxel

Dosage Form Name:

INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION

Administration Route:

Intravenous

Substances:

Name: PACLITAXEL

Strength: 100.0

Unit: mg/20mL

Packages:

Code: 60505-6230-04

Description: 1 VIAL, SINGLE-USE in 1 CARTON (60505-6230-4) / 20 mL in 1 VIAL, SINGLE-USE

Effective Date: April 1, 2022

Discontinued:

SEER*Rx Category:

Chemotherapy

Major Class:

Antimitotic Agent

Minor Class:

Taxane

Orphan Drug Designation:

Status:

In Use

CanMED and the Oncology Toolbox